2 completed, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Recruiting 1 |
Follow Acute Myeloblastic Leukemia: new trials by email Literature Review of Acute Myeloblastic Leukemia trials Research Report on Acute Myeloblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies Ceftazidime, Ciprofloxacin - Neutropenic Fever, Acute Lymphoblastic Leukemia | Phase 4 | Recruiting | Gadjah Mada University | 120 | 2025-06-01 | 2025-08-22 |
| LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML) gemtuzumab - Acute Myeloblastic Leukemia | Phase 4 | Completed | PETHEMA Foundation | 200 | 2007-10-01 | 2013-07-31 |
| SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia Fludarabine, Cytarabine, G-CSF - Myelodysplastic Syndrome, Acute Myeloblastic Leukemia | Phase 4 | Completed | PETHEMA Foundation | 200 | 1998-07-01 | 2008-11-19 |
Leukemia, Myeloid, Acute (3) · Febrile Neutropenia (1) · Lymphoma, Non-Hodgkin (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Leukemia (3) · Leukemia, Myeloid (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Agranulocytosis (1) · Bone Marrow Diseases (1) · Cytopenia (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Lymphoid (1) · Leukocyte Disorders (1) · Leukopenia (1) · Lymphatic Diseases (1)
Bone Marrow Transplantation (1) · Ceftazidime (1) · Ciprofloxacin (1) · Cytarabine (1) · Gemtuzumab (1) · Granulocyte Colony-Stimulating Factor (1) · Idarubicin (1) · Peripheral Blood Stem Cell Transplantation (1) · fludarabine (1)
PETHEMA Foundation (2) · Gadjah Mada University (1)
Spain (2) · Indonesia (1)
Sanz Miguel Angel, Dr (2) · Sanz Guillermo, Dr (1)